Pharmaceutical composition comprising a GLP-1-agonist and methionine Grant US-12303598-B2 United States of America 20 May 2025
Insulin glargine/lixisenatide fixed ratio formulation Grant US-12186374-B2 United States of America 07 Jan 2025
Treatment of diabetes mellitus by long-acting formulations of insulins Grant US-11191722-B2 United States of America 07 Dec 2021